Stocks

Synopsys Joins Elite Investment Tier with Composite Rating Soar

Published January 18, 2024

In a striking development for investors, Synopsys SNPS, a powerhouse in electronic design automation, has seen its IBD SmartSelect Composite Rating skyrocket to an impressive 98 on Wednesday—an increase from its prior rating of 94 just the previous day. This notable jump positions the company firmly ahead of 98% of all stocks when it comes to key fundamental and technical investing benchmarks. Synopsys's robust portfolio includes an array of sophisticated tools such as logic synthesis, static timing analysis, and transistor-level circuit simulation which aid in silicon design, verification, intellectual property as well as software security and quality.

“The 95-Plus Composite Rating Club”

The Composite Rating is a metric that amalgamates a variety of critical stock-selection criteria, distilling them into a singular, easy-to-understand score. By ascending to a rating of 98, Synopsys joins an elite group of companies that not only demonstrate robust earnings and strong price performance but are also backed by solid professional investor support. This accolade spotlights the company's excellence in performance compared to the broader stock market, including some of its industry peers such as Autodesk ADSK, which provides software across multiple industries, and Cadence Design Systems CDNS, known for its integrated circuits and printed circuit board design software.

Implications for Investors

For those watching the market, Synopsys's leap in rating is indeed attention-worthy, signaling potential resilience and assertiveness in the competitive market space. Investors may consider SNPS as a promising option, given its new standing in the high-performing echelon of the investing world. The advancement of SNPS might also pave the way for heightened scrutiny upon its peers, ADSK and CDNS, as market participants assess the landscape for viable technology and software investment opportunities with similar growth prospects.

Synopsys, Investment, Rating